Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Asahi Intecc Co ( (JP:7747) ) is now available.
Asahi Intecc reported strong consolidated results for the nine months ended March 31, 2026, with net sales climbing 18.0% year on year to ¥108.37 billion and operating profit jumping 45.5% to ¥37.41 billion. Profit attributable to owners of parent surged 204.2% to ¥26.66 billion, driving basic earnings per share up to ¥100.13 and lifting the equity-to-asset ratio to 81.6%.
The company plans a full-year dividend of ¥46.10 per share, up from the prior year’s ¥24.23, reflecting improved profitability and a stronger balance sheet. Asahi Intecc kept its full-year forecast unchanged, projecting net sales of ¥141.14 billion and a 139.9% rise in full-year profit to ¥30.56 billion, underscoring management’s confidence in sustained earnings growth and reinforcing its financial appeal to investors.
The most recent analyst rating on (JP:7747) stock is a Buy with a Yen4200.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
More about Asahi Intecc Co
Asahi Intecc Co., Ltd. is a Japanese medical device manufacturer listed on the Tokyo and Nagoya stock exchanges. The company develops and sells highly specialized products such as guide wires and catheters, focusing on minimally invasive cardiovascular and other medical procedures in global healthcare markets.
Average Trading Volume: 1,343,477
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen879B
For detailed information about 7747 stock, go to TipRanks’ Stock Analysis page.